These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 21698234)

  • 1. Fractal characteristics of May-Grünwald-Giemsa stained chromatin are independent prognostic factors for survival in multiple myeloma.
    Ferro DP; Falconi MA; Adam RL; Ortega MM; Lima CP; de Souza CA; Lorand-Metze I; Metze K
    PLoS One; 2011; 6(6):e20706. PubMed ID: 21698234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The fractal dimension of nuclear chromatin as a prognostic factor in acute precursor B lymphoblastic leukemia.
    Adam RL; Silva RC; Pereira FG; Leite NJ; Lorand-Metze I; Metze K
    Cell Oncol; 2006; 28(1-2):55-9. PubMed ID: 16675881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fractal dimension of chromatin is an independent prognostic factor for survival in melanoma.
    Bedin V; Adam RL; de Sá BC; Landman G; Metze K
    BMC Cancer; 2010 Jun; 10():260. PubMed ID: 20525386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fractal dimension of chromatin: potential molecular diagnostic applications for cancer prognosis.
    Metze K
    Expert Rev Mol Diagn; 2013 Sep; 13(7):719-35. PubMed ID: 24063399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computerized texture analysis of atypical immature myeloid precursors in patients with myelodysplastic syndromes: an entity between blasts and promyelocytes.
    Vido JR; Adam RL; Lorand-Metze IG; Metze K
    Diagn Pathol; 2011 Sep; 6():93. PubMed ID: 21958512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Impact of Intratumoral Heterogeneity Based on Fractal Geometry Analysis in Operated NSCLC Patients.
    Castello A; Russo C; Grizzi F; Qehajaj D; Lopci E
    Mol Imaging Biol; 2019 Oct; 21(5):965-972. PubMed ID: 30478506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic impact of circulating plasma cells in patients with multiple myeloma: implications for plasma cell leukemia definition.
    Granell M; Calvo X; Garcia-Guiñón A; Escoda L; Abella E; Martínez CM; Teixidó M; Gimenez MT; Senín A; Sanz P; Campoy D; Vicent A; Arenillas L; Rosiñol L; Sierra J; Bladé J; de Larrea CF;
    Haematologica; 2017 Jun; 102(6):1099-1104. PubMed ID: 28255016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of whole body MRI and dynamic contrast enhanced MRI in the diagnosis, follow-up and evaluation of disease activity and extent in multiple myeloma.
    Dutoit JC; Vanderkerken MA; Verstraete KL
    Eur J Radiol; 2013 Sep; 82(9):1444-52. PubMed ID: 23726124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characteristics and chromatin texture features in acute promyelocytic leukemia.
    De Mello MR; Albuquerque DM; Pereira-Cunha FG; Albanez KB; Pagnano KB; Costa FF; Metze K; Lorand-Metze I
    Diagn Pathol; 2012 Jun; 7():75. PubMed ID: 22742960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear fractal dimension as a prognostic factor in oral squamous cell carcinoma.
    Goutzanis L; Papadogeorgakis N; Pavlopoulos PM; Katti K; Petsinis V; Plochoras I; Pantelidaki C; Kavantzas N; Patsouris E; Alexandridis C
    Oral Oncol; 2008 Apr; 44(4):345-53. PubMed ID: 17692559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of the international staging system of multiple myeloma and its comparison with the DS and IFM staging system in 122 Chinese patients].
    Deng SH; Xu Y; Mai YJ; Wang YF; Zhao YZ; Zou DH; Qiu LG
    Zhonghua Xue Ye Xue Za Zhi; 2008 Apr; 29(4):217-21. PubMed ID: 18843972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Revised International Staging System (R-ISS) for transplant-eligible multiple myeloma patients.
    González-Calle V; Slack A; Keane N; Luft S; Pearce KE; Ketterling RP; Jain T; Chirackal S; Reeder C; Mikhael J; Noel P; Mayo A; Adams RH; Ahmann G; Braggio E; Stewart AK; Bergsagel PL; Van Wier SA; Fonseca R
    Ann Hematol; 2018 Aug; 97(8):1453-1462. PubMed ID: 29623394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear fractal dimension in oral squamous cell carcinoma: a novel method for the evaluation of grading, staging, and survival.
    Mincione G; Di Nicola M; Di Marcantonio MC; Muraro R; Piattelli A; Rubini C; Penitente E; Piccirilli M; Aprile G; Perrotti V; Artese L
    J Oral Pathol Med; 2015 Oct; 44(9):680-4. PubMed ID: 25367085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of Structural Heterogeneity Using Fractal Analysis of Contrast-Enhanced CT Image to Predict Survival in Gastric Cancer Patients.
    Watanabe H; Hayano K; Ohira G; Imanishi S; Hanaoka T; Hirata A; Kano M; Matsubara H
    Dig Dis Sci; 2021 Jun; 66(6):2069-2074. PubMed ID: 32691383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prognostic value of the new international staging system in multiple myeloma. Comparison with Durie-Salmon staging system].
    Conté L G; Figueroa M G; Lois V V; Cabrera C ME; León R A; García L H; Rojas R H
    Rev Med Chil; 2008 Jan; 136(1):7-12. PubMed ID: 18483648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Revised International Staging System Compared to the Classical International Staging System Better Discriminates Risk Groups among Transplant-Ineligible Multiple Myeloma Patients.
    Bila J; Jelicic J; Dencic Fekete M; Trajkovic G; Sretenovic A; Perunicic Jovanovic M; Antic D; Mihaljevic B
    Oncol Res Treat; 2017; 40(10):616-620. PubMed ID: 28950269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Revised International Staging System Is Predictive and Prognostic for Early Relapse (<24 months) after Autologous Transplantation for Newly Diagnosed Multiple Myeloma.
    Gopalakrishnan S; D'Souza A; Scott E; Fraser R; Davila O; Shah N; Gale RP; Kamble R; Diaz MA; Lazarus HM; Savani BN; Hildebrandt GC; Solh M; Freytes CO; Lee C; Kyle RA; Usmani SZ; Ganguly S; Assal A; Berdeja J; Kanate AS; Dhakal B; Meehan K; Kindwall-Keller T; Saad A; Locke F; Seo S; Nishihori T; Gergis U; Gasparetto C; Mark T; Nieto Y; Kumar S; Hari P
    Biol Blood Marrow Transplant; 2019 Apr; 25(4):683-688. PubMed ID: 30579965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple myeloma staging based on the combination of beta-2-microglobulin and albumin: the role of albumin in the model.
    Mihou D; Katodritou E; Zervas K
    Hematology; 2007 Dec; 12(6):527-31. PubMed ID: 17852450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of bone marrow angiogenesis in multiple myeloma: use of light microscopy as well as computerized image analyzer in the assessment of microvessel density and total vascular area in multiple myeloma and its correlation with various clinical, histological, and laboratory parameters.
    Bhatti SS; Kumar L; Dinda AK; Dawar R
    Am J Hematol; 2006 Sep; 81(9):649-56. PubMed ID: 16845660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of prognostic staging systems of multiple myeloma in the era of novel agents.
    Shang Y; Jin Y; Liu H; Ding L; Tong X; Tu H; Zang L; Lin C; Hu J; Zhou F
    Hematol Oncol; 2022 Apr; 40(2):212-222. PubMed ID: 34860428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.